Stocks
Cara Therapeutics (CARA) P/FCF US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -122.9 | -10.3 | -7.32 | -0.43 | -0.84 | ||||
| Changes by years, y/y, % | +1 853% | -92% | -29% | -100% | -54.1% | ||||
Cara Therapeutics. P/FCF
Cara Therapeutics. P/FCF, changes, %
Cara Therapeutics (CARA) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -0.54 | -0.43 | -0.55 | -0.17 | -0.22 | -0.84 | ||
| Changes by years, y/y, % | -93% | -94% | -82% | -88% | -76% | |||
| Changes by quarters, q/q, % | -42% | -21% | +27% | -69% | +29% | |||
